Connor, Clark & Lunn Investment Management (CC&L)’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5M Sell
782,798
-92,503
-11% -$596K 0.01% 685
2025
Q4
$5.21M Sell
875,301
-68,171
-7% -$362K 0.01% 634
2025
Q3
$5.01M Buy
943,472
+43,216
+5% +$183K 0.02% 578
2025
Q2
$3.09M Buy
900,256
+68,567
+8% +$219K 0.01% 725
2025
Q1
$2.46M Buy
831,689
+344,321
+71% +$1.08M 0.01% 676
2024
Q4
$1.49M Buy
487,368
+118,913
+32% +$346K 0.01% 809
2024
Q3
$940K Buy
368,455
+13,941
+4% +$42.2K ﹤0.01% 903
2024
Q2
$1.16M Sell
354,514
-31,349
-8% -$138K ﹤0.01% 815
2024
Q1
$2.05M Buy
385,863
+189,204
+96% +$1.02M 0.01% 666
2023
Q4
$852K Sell
196,659
-3,108
-2% -$10.3K ﹤0.01% 904
2023
Q3
$525K Hold
199,767
﹤0.01% 1001
2023
Q2
$705K Buy
199,767
+15,822
+9% +$49.4K ﹤0.01% 893
2023
Q1
$568K Buy
183,945
+675
+0.4% +$2.54K ﹤0.01% 848
2022
Q4
$775K Buy
183,270
+33,976
+23% +$117K ﹤0.01% 770
2022
Q3
$354K Buy
149,294
+71,703
+92% +$209K ﹤0.01% 882
2022
Q2
$221K Sell
77,591
-13,140
-14% -$32.7K ﹤0.01% 912
2022
Q1
$261K Sell
90,731
-9,484
-9% -$24.5K ﹤0.01% 901
2021
Q4
$305K Buy
+100,215
New +$435K ﹤0.01% 892
2020
Q2
Sell
-11,467
Closed -$97K 1143
2020
Q1
$97K Buy
+11,467
New +$111K ﹤0.01% 936
2016
Q4
Sell
-3,925
Closed -$263K 960
2016
Q3
$263K Sell
3,925
-22,800
-85% -$1.15M ﹤0.01% 696
2016
Q2
$796K Sell
26,725
-525
-2% -$16.4K 0.01% 505
2016
Q1
$800K Sell
27,250
-2,100
-7% -$94.9K 0.01% 494
2015
Q4
$2.3M Sell
29,350
-6,525
-18% -$512K 0.02% 309
2015
Q3
$2.7M Buy
35,875
+275
+0.8% +$26K 0.02% 262
2015
Q2
$4.16M Buy
35,600
+600
+2% +$109K 0.04% 169
2015
Q1
$8.26M Buy
35,000
+14,100
+67% +$3.01M 0.07% 129
2014
Q4
$3.96M Buy
20,900
+12,300
+143% +$2.73M 0.03% 175
2014
Q3
$2.05M Buy
+8,600
New +$1.77M 0.02% 214

Other funds holding PBYI